|
TCEA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.17720000414323E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.96410000170056E-08 |
| Normal-vs-Stage2 |
4.009600E-01 |
| Normal-vs-Stage3 |
3.67483821150927E-13 |
| Normal-vs-Stage4 |
2.63759999996616E-06 |
| Stage1-vs-Stage2 |
1.456050E-01 |
| Stage1-vs-Stage3 |
5.423900E-03 |
| Stage1-vs-Stage4 |
1.686240E-01 |
| Stage2-vs-Stage3 |
1.332030E-02 |
| Stage2-vs-Stage4 |
3.560100E-02 |
| Stage3-vs-Stage4 |
8.288200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.10199627201268E-11 |
| Normal-vs-AfricanAmerican |
4.54980000008653E-07 |
| Normal-vs-Asian |
3.763100E-04 |
| Caucasian-vs-AfricanAmerican |
5.973600E-01 |
| Caucasian-vs-Asian |
3.927600E-01 |
| AfricanAmerican-vs-Asian |
3.147800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.59290000079082E-08 |
| Normal-vs-Female |
1.90650000231329E-08 |
| Male-vs-Female |
3.481200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.39639999960661E-08 |
| Normal-vs-Age(41-60Yrs) |
9.39089994655973E-09 |
| Normal-vs-Age(61-80Yrs) |
1.52210000003983E-06 |
| Normal-vs-Age(81-100Yrs) |
2.981600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.440200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.258200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.491000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.922800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.248200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.107200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.378000E-02 |
| Classical-VS-Follicular |
2.051700E-02 |
| Classical-VS-Other |
4.727800E-01 |
| Classical-VS-Normal |
1.34449995581321E-09 |
| Tall-VS-Follicular |
1.059010E-03 |
| Tall-VS-Other |
9.206800E-01 |
| Tall-VS-Normal |
1.32550004305898E-09 |
| Follicular-VS-Other |
2.921800E-02 |
| Follicular-VS-Normal |
2.393200E-01 |
| Other-VS-Normal |
4.001800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.95198999999313E-05 |
| Normal-vs-N1 |
2.71290000464219E-08 |
| N0-vs-N1 |
2.032200E-02 |
|
|
